Tobacco flavor study seeks to understand Vapers' sense of smell and taste
NCT ID NCT04358315
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well people can identify and rate different flavors and smells in e-liquids. Researchers compared the abilities of everyday vapers and trained experts to detect flavors, find the lowest detectable levels, and pick out the main flavor in mixtures. The goal was to learn more about how consumers perceive tobacco product flavors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
29 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Current daily vapers and nonusers in the greater Buffalo and Rochester areas
- Ages
-
21 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * CONSUMER USER: Current daily vapers of products containing nicotine * CONSUMER USER: No concurrent use of other tobacco products * CONSUMER USER: General good health * CONSUMER USER: No allergies * CONSUMER USER: No self-reported taste or smell deficits * CONSUMER USER: Not pregnant or lactating * CONSUMER USER: No medications known to interfere with taste/smell * CONSUMER USER: Passing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests * CONSUMER USER: No positive diagnosis of COVID-19 within 30 days * CONSUMER NONUSER: No use of tobacco or nicotine products in the last year * CONSUMER NONUSER: General good health * CONSUMER NONUSER: No allergies * CONSUMER NONUSER: No self-reported taste or smell deficits * CONSUMER NONUSER: Not pregnant or lactating * CONSUMER NONUSER: No medications known to interfere with taste/smell * CONSUMER NONUSER: Passing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests * CONSUMER NONUSER: No positive diagnosis of COVID-19 within 30 days Exclusion Criteria: * CONSUMER USER: Outside age range * CONSUMER USER: Not current daily vapers * CONSUMER USER: Concurrent use of other tobacco products * CONSUMER USER: Fair or poor general health * CONSUMER USER: Allergies * CONSUMER USER: Self-reported taste or smell deficits * CONSUMER USER: Pregnant or lactating * CONSUMER USER: Medications known to interfere with taste/smell * CONSUMER USER: Failing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests * CONSUMER USER: Positive diagnosis of COVID-19 within 30 days * CONSUMER NONUSER: Outside age range * CONSUMER NONUSER: Use of tobacco or nicotine products in the last year * CONSUMER NONUSER: Fair or poor general health * CONSUMER NONUSER: Allergies * CONSUMER NONUSER: Self-reported taste or smell deficits * CONSUMER NONUSER: Pregnant or lactating * CONSUMER NONUSER: Medications known to interfere with taste/smell * CONSUMER NONUSER: Failing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests * CONSUMER NONUSER: Positive diagnosis of COVID-19 within 30 days
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Current vaper are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Lifestyle makeover: can diet and exercise curb cancer risk?
- Brain mapping study probes how we sense and move
- Can MRI and tissue tests predict breast cancer before it starts?
- Scientists seek immune system clues from cancer patients and healthy volunteers
- Peer education may boost genetic cancer screening in black men
- Omega-3 showdown: which DHA type reaches the brain best?